Global and China Hemodialysis Industry Report, 2013-2016
  • May 2014
  • Hard Copy
  • USD $2,550
  • Pages:109
  • Single User License
    (PDF Unprintable)       
  • USD $2,400
  • Code: HK043
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $3,700
  • Hard Copy + Single User License
  • USD $2,750

Hemodialysis, also known as artificial kidney, is a type of blood purification technology, primarily applicable to the treatment of patients with rental failure.

In 2013, the global number of patients receiving dialysis continued to grow to 2.519 million. The new patients mainly come from Asia Pacific region (excluding Japan), whereas for Europe, America, Japan and other mature markets, since these countries have a higher proportion of patients with advanced renal failure receiving treatment, so they have a slower growth in the number of patients receiving dialysis. For example, in 2013, the number of patients receiving dialysis in Asia-Pacific region grew by 17.0% YoY; while in Japan, EU and US, the number of patients receiving dialysis grew by only 2%-4% YoY.

The global hemodialysis market can be divided into two parts: hemodialysis service and hemodialysis equipment, of which the scale of hemodialysis service market is larger, accounting for about 85% of the overall market.

1 Hemodialysis Service Market

Global hemodialysis service market has great regional differences: in Europe and Asia Pacific, public institutions dominate, however, in North America, private-company-operated institutions and in Latin America, private clinics are the main forms. Currently, global companies providing hemodialysis service mainly include Fresenius Medical Care, DaVita, etc. The number of patients receiving hemodialysis in these two companies in 2013 came to nearly 340,000.

Dialysis services in China are mainly provided by all levels of hospitals, mainly due to that currently the national health insurance reimbursement ratio is relatively low and the affordability of patients is not high, resulting in lower proportion of patients with end-stage renal disease undergoing dialysis treatment, which was only about 12% in 2013. In 2013 the number of Chinese patients with renal failure undergoing dialysis treatment (mainly hemodialysis treatment) was approximately 250,000, and number of patients undergoing peritoneal dialysis was less than 30,000. But with the gradual expansion of China's health insurance coverage at all levels, the proportion of patients with end stage renal disease undergoing treatment will rise sharply and the market prospects will be very promising.

2 Dialysis Equipment Market

The global hemodialysis equipment market is relatively concentrated, mainly dominated by European, American and Japanese companies. The first-tier brands are American and European brands, including Germany-based Fresenius and Braun, U.S.-based Baxter and so on; the second-tier brands mainly are Japanese brands, including NIKKISO, Nipro, Toray and so on. In 2013, market share of Fresenius and Baxter in the global dialysis equipment market reached 34% and 30% respectively.

Local Chinese hemodialysis equipment has poor competitiveness and low market share. In 2013, China's hemodialysis equipment import dependency rate was about 70%. Chinese manufacturers in the field of dialysis include: hemodialysis machine manufacturers like Jihua Medical Apparatus and Instruments Co., Ltd, Guangdong Biolight Meditech Co., Ltd and Chongqing Shanwaishan Science & Technology Co., Ltd; dialyzer manufacturers include Shandong Weigao Group and Jiangsu Lengthen Life Science and Technology Co., Ltd; peritoneal dialysis solution manufacturers include Huaren Pharmaceutical Co., Ltd and Sichuan Kelun Pharmaceutical Co., Ltd.


The "Global and China Hemodialysis Industry Report, 2013-2016" published by ResearchInChina includes the following main contents:
20120114.gifGlobal hemodialysis population and distribution, etc.;
20120114.gifStatus quo, competition pattern and development trend of the global hemodialysis equipment and service markets;
20120114.gifMarket scale, competition pattern, import & export and development forecasting, etc of China hemodialysis industry;
20120114.gifStatus quo and competition pattern of global and China hemodialysis equipment market segments;
20120114.gifOperational analysis, hemodialysis business analysis and development forecasting of 16 global and Chinese enterprises in the hemodialysis industry.

1 Hemodialysis Industry Overview
1.1 Definition
1.2 Hemodialysis Equipment
1.3 Hemodialysis Service
1.3.1 In-Center Hemodialysis
1.3.2 Home Hemodialysis
1.4 Industry Chain

2 Global Hemodialysis Market
2.1 Dialysis Population
2.2 Overall Market Situation
2.3 Hemodialysis Equipment Market
2.4 Hemodialysis Service Market

3 China Hemodialysis Market
3.1 Status Quo
3.2 Policy Environment
3.3 Competition Pattern
3.4 Market Scale

4 China Hemodialysis Equipment Import and Export 
4.1 Import
4.2 Export

5 Hemodialysis Market Segments
5.1 Hemodialysis Machine
5.2 Peritoneal Dialysis
5.3 Dialyzer
5.4 Dialysis Loop Tube
5.5 Dialysis Concentrate
5.6 Hemodialysis Machine for Home Use
5.7 Hemodialysis Membrane

6 Major Foreign Manufacturers
6.1 Fresenius Medical Care
6.1.1 Profile
6.1.2 Operation
6.1.3 Dialysis Product Business
6.1.4 Dialysis Service Business
6.1.5 Number of Patients Receiving Dialysis
6.1.6 Development Situation
6.1.7 Business in China
6.2.1 Profile
6.2.2 Operation
6.2.3 Hemodialysis Business
6.2.4 Business in China
6.3 Baxter
6.3.1 Profile
6.3.2 Operation
6.3.3 Hemodialysis Business
6.3.4 Acquisition of Gambro AB
6.3.5 Operating Conditions in China
6.4 Asahi Kasei
6.4.1 Profile
6.4.2 Operation
6.4.3 Operating Conditions of the Health Care Division
6.4.4 Business in China
6.5 Nipro
6.5.1 Profile
6.5.2 Operation
6.5.3 Hemodialysis Business
6.5.4 Business in China
6.6 B. Braun Melsungen AG
6.6.1 Profile
6.6.2 Operation
6.6.3 Hemodialysis Business
6.6.4 Business in China
6.7 Nxstage
6.7.1 Profile
6.7.2 Operation
6.7.3 Portable Hemodialysis Machine Business
6.7.4 Hemodialysis Consumables Business

7 Major Manufacturers in China
7.1 Weigao Group
7.1.1 Profile
7.1.2 Operation
7.1.3 Revenue Structure
7.1.4 R & D
7.1.5 Hemodialysis Business
7.1.6 Development Prospects and Forecasting
7.2 Huaren Pharmaceutical
7.2.1 Profile
7.2.2 Operation
7.2.3 Hemodialysis Business
7.3 Guangdong Biolight Meditech
7.3.1 Profile
7.3.2 Operation
7.3.3 Revenue Structure
7.3.4 Gross Margin
7.3.5 R & D
7.3.6 Clients
7.3.7 Hemodialysis Business
7.3.8 Forecasting and Outlook
7.4 Kelun Pharmaceutical
7.4.1 Profile
7.4.2 Operation
7.4.3 Hemodialysis business
7.5 Jihua Medical Apparatus and Instruments
7.5.1 Profile
7.5.2 Hemodialysis Business
7.6 Bain Medical Equipment
7.6.1 Profile
7.6.2 Operation
7.6.3 Hemodialysis Business
7.7 Beijing United Bio-Tech
7.7.1 Profile
7.7.2 Operation
7.8 Jiangsu Lengthen Life Science and Technology
7.8.1 Profile
7.8.2 Operation
7.8.3 Hemodialysis Business
7.9 Guangzhou Koncen BioScience
7.9.1 Profile
7.9.2 Operation

8 Summary and Forecasting
8.1 Summary
8.2 Development Forecasting
8.2.1 Increasing Hemodialysis Population 
8.2.2 Steadily Increasing Proportion of Dialysis Treatment 
8.2.3 Market Size Forecasting
Pros and Cons of In-Center Hemodialysis
Pros and Cons of Home Hemodialysis
Hemodialysis Industry Chain
Global Number of Nephritic Patients Receiving Dialysis, 1990-2020E
Global Number of Patients Receiving Dialysis Treatment, 2011-2013
Patients Receiving Dialysis Treatment Worldwide by Region, 2011-2013 
Patients Receiving Dialysis Treatment Worldwide by Country, 2011-2013 
Competition Structure of Global Dialysis Equipment Market, 2013
Competition Structure of Global Hemodialysis Machine Market, 2013
Competition Structure of Global Peritoneal Dialysis Equipment Market, 2013
Global Number of Patients with Advanced Renal Failure by Treatment Method, 2011-2013 
Proportions of Global Number of Patients with Advanced Renal Failure (by Treatment Method), 2011-2013
Service Forms of Global Dialysis Industry (by Region), 2013
Service Forms of Major Countries and Regions in Global Dialysis Industry, 2013
Number of Patients Receiving Dialysis at the World's Top Five Dialysis Service Providers, 2013
Number of Patients Receiving Dialysis at the World’s Leading Hemodialysis Service Providers (by Region), 2013
Amount of China’s Hemodialysis Equipment Trade Deficit, 2008-2013
Products of China’s Major Hemodialysis Machine Manufacturers Holding Medical Device Registration Certificate, 2013  
Geographical Distribution of Chinese Dialysis Equipment Manufacturers, 2013
China's Dialysis Market Size, 2013
China's Hemodialysis Equipment Import Value and Growth Rate, 2009-2013
China's Hemodialysis Equipment Import Volume and Growth Rate, 2009-2013
China's Hemodialysis Equipment Import Source Structure (by Import Value), 2011-2013
Comparison by Average Unit Price of China’s Hemodialysis Equipment Imports (by Country), 2011-2013
China’s Hemodialysis Equipment Import Value Structure by Province/City, 2011-2013
China's Hemodialysis Equipment Export Value and Growth Rate, 2009-2013
China's Hemodialysis Equipment Export Destination Structure (by Export Value), 2013
China's Hemodialysis Equipment Export Value Structure by Province/City, 2013
Introduction of Some Small Hemodialysis Machines 
Five Branches of Fresenius Group 
Net Revenue and Net Income of Fresenius Medical Care, 2009-2013
Net Revenue Structure of Fresenius Medical Care (by Product), 2011-2013
Net Revenue Structure of Fresenius Medical Care (by Region), 2011-2013
Net Revenue and Growth Rate of Dialysis Products of Fresenius Medical Care, 2009-2013
Net Revenue Structure of Dialysis Products of Fresenius Medical Care (by Region), 2011-2013
Revenue and Growth Rate of Dialysis Service of Fresenius Medical Care, 2009-2013
Net Revenue Structure of Dialysis Service of Fresenius Medical Care (by Region), 2011-2013
Number of Patients Receiving Dialysis Treatment at Fresenius Medical Care and YoY Growth Thereof, 2009-2013
Proportion of Patients Receiving Dialysis Treatment at Fresenius Medical Care (by Region), 2011-2013
Market Share of Fresenius Medical Care in the World's Major Markets (by Number of Patients Receiving Dialysis), 2013
Production Plants and Main Products of Fresenius Medical Care, 2013
Operation of Fresenius Medical Care's Subsidiaries in China, 2013
Main Business of NIKKISO by Division, 2013
Net Sales and Net Income of NIKKISO, FY2008-FY2012
Net Sales Structure of NIKKISO (by Division), FY2012
Net Sales Structure of NIKKISO (by Region), FY2012
Hemodialysis-Related Factories of NIKKISO, 2013
Net Sales and YoY Growth of Medical Division of NIKKISO, FY2008-FY2012
Main Business and Products of Baxter
Net Sales and Net Income of Baxter, 2009-2013
Net Sales Structure of Baxter (by Division), 2011-2013
Net Sales Structure of Baxter (by Region), 2011-2013
Net Sales Structure of Medical Products Division of Baxter (by Product), 2011-2013
Net Sales and YoY Growth of Renal Business of Baxter, 2009-2013
Net Sales Structure of Renal Business of Baxter (by Region), 2010-2012
Net Sales and EBITDA of Gambro AB, 2008-2012
Main Business of Baxter’s Factories in China, 2012
Main Business of Nine Core Operating Companies of Asahi Kasei
Net Sales and Net Income of Asahi Kasei, FY2008-FY2012 
Net Sales Structure of Asahi Kasei (by Division), FY2010-FY2012
Net Sales and Operating Income of Health Care Division of Asahi Kasei, FY2008-FY2012
Major Affiliates of Asahi Kasei Medical
Operating Revenue and Operating Income of Asahi Kasei Medical (Hangzhou), 2007-2009
Three Major Business Segments and Specific Business of Nipro
Net Sales and Net Income of Nipro, FY2008-FY2012
Sales Structure of Nipro (by Business), FY2012
Sales Structure of Nipro (by Region), FY2012
Net Sales and Operating Income of Medical-Care-Related Business of Nipro, FY2008-FY2012 
Net Sales and Operating Income of Pharmaceutical-Related Business of Nipro, FY2008-FY2012
Business of Nipro’s Subsidiaries in China
Hemodialysis Products of Nipro Trading (Shanghai) 
Operating Revenue and Total Profit of Nipro Trading (Shanghai), 2007-2009
Main Business of Four Divisions of B.Braun 
Sales and EBITDA of B.Braun, 2009-2013
Sales Structure of B.Braun (by Division), 2011-2013
Sales Structure of B.Braun (by Region), 2011-2013
Sales Structure of B.Braun (by Product and Service), 2011-2013
Sales and YoY Growth of B.Braun Avitum, 2009-2013
Main Business of B.Braun’s Subsidiaries in Mainland China, 2013
Sales of B.Braun Avitum (Shanghai) Trading Company Limited, 2009-2013
Main Business Divisions and Business of Nxstage 
Total Revenue and Gross Profit of Nxstage, 2009-2013 
Revenue Structure of Nxstage (by Division), 2011-2013
Revenue and Gross Profit of Portable Hemodialysis Machine Division of Nxstage, 2009-2013
Revenue Structure of Portable Hemodialysis Machine Division of Nxstage (by Business), 2011-2013
Revenue and Gross Profit of Hemodialysis Consumables of Nxstage, 2008-2012
Product Line of Weigao Group
Revenue and Net Income of Weigao Group, 2009-2013
Revenue Breakdown of Weigao Group (by Product), 2011-2013
Output of Main Products of Weigao Group, 2011-2013
Revenue Structure of Weigao Group (by Product), 2011-2013
Revenue Breakdown of Weigao Group (by Region), 2011-2013
Revenue Structure of Weigao Group (by Region), 2011-2013
R&D Costs and % of Total Revenue of Weigao Group, 2010-2012
Hemodialysis-Related Subsidiaries of Weigao Group, 2013
Revenue and Net Income of Weigao Group, 2012-2016E
Revenue and Net Income of Huaren Pharmaceutical, 2009-2013
Revenue and Net Income of Guangdong Biolight Meditech, 2009-2013
Revenue Breakdown of Guangdong Biolight Meditech (by Product), 2011-2013
Revenue Structure of Guangdong Biolight Meditech (by Product), 2011-2013
Revenue Breakdown of Guangdong Biolight Meditech (by Region), 2011-2013
Revenue Structure of Guangdong Biolight Meditech (by Region), 2011-2013
Gross Margin of Main Products of Guangdong Biolight Meditech, 2011-2013
R&D Costs and % of Total Revenue of Guangdong Biolight Meditech, 2011-2013
Guangdong Biolight Meditech’s Revenue from Top 5 Clients and % of Total Revenue, 2011-2013
Name List, Revenue Contribution and % of Guangdong Biolight Meditech's Top 5 Clients, 2013
Hemodialysis-Related Subsidiaries of Guangdong Biolight Meditech, 2013
Output and Sales Volume of Dialysis Solution/Powder of Guangdong Biolight Meditech, 2012-2013
Revenue and Net Income of Guangdong Biolight Meditech, 2012-2016E
Revenue and Net Income of Kelun Pharmaceutical, 2009-2013
Revenue and Net Income of Chengdu Qingshan Likang Pharmaceutical, 2012-2013
Hemodialysis Series Products of Jihua Medical Apparatus and Instruments
Operating Revenue, Total Profit and Gross Margin of Bain Medical Equipment, 2008-2009
Operating Revenue, Total Profit and Gross Margin of Beijing United Bio-Tech, 2007-2009
Operating Revenue, Total Profit and Gross Margin of Jiangsu Lengthen Life Science and Technology, 2007-2009
Shareholding Structure of Guangzhou Koncen Bioscience as of 2013
Product Line of Guangzhou Koncen Bioscience
Key Financial Indicators of Guangzhou Koncen Bioscience, 2012-2013
Operation Comparison between Global and Chinese Hemodialysis Enterprises, 2013
Positive Correlation between the Number of ESRD Patients per Million Population and GDP Per Capita
China Hemodialysis Market Size, 2013-2016E

China Blood Product Industry Report, 2020-2027

With the adjustment in the catalog of medicines covered by national medical insurance system, the scope and reimbursement ratio of almost all blood products for clinical use grow tremendously, which h...

China Medical Robot Industry Report, 2020-2026

Medical robot is the most promising segment of service robot market. By one estimate, globally 7,200 units of medical robots were sold and valued at $2.58 billion in 2019, compared with 5,100 units (u...

China In Vitro Diagnostic (IVD) Industry Report, 2019-2025

In vitro diagnosis (IVD) as a good way to make a rapid and definite diagnosis of diseases early, plays an increasingly crucial role in clinical medicine and related medical research fields. China’s IV...

China Aged Care Industry Report, 2019-2025

China’s society has aged before it gets rich. By the end of 2018, people aged over 60 had numbered 249.5 million in the country, or 17.9% of the total population, of which those aged over 65 were 167 ...

China Dental Industry Report, 2019-2025

Nowadays, the Chinese people have a growing awareness of oral health and healthy behaviors. 60.1% of residents have knowledge about oral health; 24.1% of 5-year-old children and 31.9% of 12-year-old c...

China Hospital Industry Report,2019-2025

The people’s growing awareness of health care and the acceleration of population aging have brought prosperity to China’s hospital industry. As of February 2019, there had been a total of 33,000 hospi...

China Dental Industry Report, 2017-2021

As living standards continue to improve and the awareness of oral health grows, consumers’ demand for dental services has kept increasing and the dental industry in China has witnessed robust developm...

China Interferon Industry Report, 2016-2021

Interferon is mainly used for the treatment of hepatitis B, hepatitis C, multiple sclerosis, condyloma acuminatum and other diseases. Wherein, IFN-α is mainly suitable for curing hepatitis B and hepat...

China Hospital Industry Report,2016-2020

In recent years, "Opinions on Promoting the Development of Health Service Industry" and other related policies, the people’s growing awareness of health care and the acceleration of population aging h...

China Aged Care Industry Report, 2016-2020

China entered the aging society early in 1999. By the end of 2015, China’s population aged over 60 reached 222 million and the old-age dependency ratio 13.9%. By 2020, China’s population aged over 60 ...

China Medical Robotics Industry Report, 2016-2020

Medical robotics can be used in surgery, rescue, transport, care, rehabilitation, dispensing and so on for the sick and wounded. Especially, surgical, rehabilitation and dispensing robots are the R &a...

China Dental Industry Report, 2016-2020

The dental industry refers to medical industrial chain on the basis of oral medical consumption, consisting mainly of dental apparatus (equipments and consumables), dental medical services, etc. With ...

China Medical Imaging Diagnosis Industry Report, 2015-2019

Against the background of a surge in social demand, handsome profit and the favorable opportunity brought by health care reform, the medical imaging industry, especially medical imaging equipment indu...

China Heparin Industry Report, 2015-2018

As the world's largest heparin API producer and exporter, China seizes about 80% share of the global heparin API market. After the explosive growth in 2008-2010, the stagnant international market and ...

Global and China Stem Cell Industry Report, 2015-2018

Stem cells are undifferentiated biological cells that can differentiate into specialized cells and can divide (through mitosis) to produce more stem cells. Currently, stem cells are used to treat hund...

China Hospital Industry Report, 2015-2018

Stimulated by the demand, the number of hospitals in China rose from 21,979 in 2011 to 26,479 at the end of May 2015, an increase of 4,500 in total. Among them, public hospitals showed an overall decl...

China Independent Clinical Laboratory Industry Report, 2015-2018

The independent clinical laboratory originated from the U.S. and is relatively mature in developed countries/regions like North America, Europe, and Japan, whose independent clinical laboratory market...

China Medical Robot Industry Report, 2014-2018

Medical robots can be applied to surgeries, rescue, transport, nursing and rehabilitation of the sick and wounded. Wherein, surgery and rehabilitation robots are two striking market segments. Due to ...

2005- All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号